California looks to take lead in combating pay-for-delay settlements
Federal lawmakers have tried unsuccessfully for years to pass legislation to curb pay-for-delay agreements where branded drugmakers pay rivals to keep generic drugs from coming to market. Now, a California state...
Subscription required to view this article.
This content can only be accessed by FTCWatch subscribers. If you are an FTCWatch subscriber, please login to access this content